Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41523-020-0155-1
PubMed Identifier: 32436923
Publication URI: http://europepmc.org/abstract/MED/32436923
Type: Journal Article/Review
Volume: 6
Parent Publication: NPJ breast cancer
ISSN: 2374-4677